ACCC association of cancer care centers
Join/Renew
Login
Join/Renew
Login
Education & Resources
ACCC eXchange LogInCorporate Member Sponsored ResourcesACCC eLearning LogInPresentations & Abstracts
Publications
Oncology IssuesPatient Assistance & Reimbursement GuideTrending Now in Cancer CareBusiness Case Studies for Hiring New Staff
Events
2026 ACCC Leadership SummitAnnual Meeting & Cancer Center Business SummitCapitol Hill DayNational Oncology ConferenceOncology Reimbursement MeetingsOncology State Society Meetings
Policy & Advocacy
ACCC 2026 Policy PrioritiesLetters & StatementsAccess, Payment & Reimbursement ReformWhite Bagging & Brown BaggingAdvocacy ResourcesCancer Moonshot
Membership
Join | RenewWho We AreMembership Types & BenefitsCorporate MembersACCC Member Portal FAQMember Directory
Partners
Oncology State SocietiesPartner OrganizationsCME
News
News ReleasesAdvocacy News ReleasesOncology News
About ACCC
Timeline / 50th Anniversary2025 Impact ReportPresident's ThemeACCC Innovator AwardsACCC FellowsBoard of TrusteesACCC Senior Staff
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
Join/Renew
Login
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
    • Education & Resources
    • Publications
    • Events
    • Policy & Advocacy
    • Membership
    • Partners
    • News
    • About ACCC
ACCC association of cancer care centers
5425 Wisconsin Ave #600, Chevy Chase, MD 20815
Tel: 301.984.9496 Email Us
Contact UsVolunteers
Advertise
Career Center
Terms and Conditions
Privacy Policy
ACCC Rebranding
Copyright © 2026 Association of Cancer Care Centers. All Rights Reserved.
HomePublicationsOncology Issues

Restoring Wholeness: The Role of Paramedical Tattooing in Continuous Cancer Care

April 13, 2026
Oncology Issues
April 2026
Volume 41
Issue 2

Author(s):

Taylor Keeney

Restoring Wholeness: The Role of Paramedical Tattooing in Continuous Cancer Care
Download Issue PDFDownload PDF

From the moment a woman hears the words “You have breast cancer,” her life as she knows it is forever changed. Her schedule suddenly fills with scans, biopsies, surgeries, chemotherapy, and radiation. Her body becomes a battleground. Her identity, once rooted in a sense of control, femininity, and confidence, begins to shift as she moves through a medical system focused on survival. While surviving cancer is a profound victory, for many, what follows is not the peace they expected, but a complex, lingering sense of incompleteness.

Even after active treatment ends, survivors often find themselves navigating the invisible terrain of emotional healing, identity restoration, and physical acceptance. The scars left behind are not just on the skin—they live in mirrors, in quiet moments, and in the vulnerability of intimacy. Yet this deeply personal phase of the cancer journey is rarely addressed with the same urgency and compassion as diagnosis and treatment.

A Niche but Growing Field

This is where continuous cancer care becomes essential. Within this continuum, paramedical tattooing—specifically, areola restoration—has a profoundly important role. Paramedical means supplementing the work of highly trained medical professionals. When you describe a paramedical tattoo artist, you are talking about an artist specializing in work that follows or enhances treatments of medical conditions. This is a very important credential for patients seeking areola restoration, because there are thousands of talented tattoo artists in the world, but not all have the proper training and experience to work with skin that has been altered and often compromised due to various medical treatments and conditions.

Despite the remarkable progress the breast cancer community has made—targeted therapies, innovative surgical options, increasing survival rates—there remains a significant gap in postoperative care. Far too many patients complete reconstruction only to be left with breasts that feel unfinished. While their doctors may consider the process “complete,” the patient often does not.

When I began my career in paramedical tattooing in 2020, I first heard about it through Instagram, where it is very popular in the United Kingdom and supported by a thriving community of full-time artists. I started researching training courses in the United States and quickly discovered that there was almost nothing available—only 3 artists in the entire country that I could find—so my resources for learning the profession were extremely limited. From the women I speak with who have gone through the reconstructive process, I have learned that they often are not receiving this information either.

An Underutilized but Crucial Service

I have met countless survivors who were unaware that realistic areola tattoos were an option. Many were never told. Others were told they could receive tattoos, only to be referred to someone who lacked the training necessary to work with their delicate, surgically altered skin. Some patients, like my great aunt, endured the pain of receiving subpar results from an in-house provider who lacked both technical skill and trauma-informed awareness. These stories are not outliers—they are alarmingly common.

To recognize this gap, New York State introduced Bill A5729A in 2024, legislation that requires certain insurers to provide coverage for tattooing performed by a physician as part of breast reconstruction.1 While this bill marks an important shift in acknowledging the medical value of areola tattooing, its implementation and impact remain limited.

This bill was passed with the good intention of providing coverage for areola tattoos as part of breast cancer care in New York through medical insurance. But it specifically notes that a physician must be the one to perform the tattooing, so that comes with limitations. As a professional tattoo artist, I am not covered under the bill, and physicians are often forced to take time away from their schedules to learn a new skill. As a result, the bill does not afford patients the best opportunity for optimal outcomes.

Under the Women’s Health and Cancer Rights Act in 1998, most group health plans that cover mastectomies are required to also cover breast cancer reconstruction and related procedures.2 But it does not specifically mention tattoos as part of the reconstructive process, so it leaves their inclusion up to the interpretation of the insurance company state by state. As a result, survivors face additional complications during what is meant to be the final step in the breast cancer care continuum.


Top: Before paramedical tattoos (areola restoration) 

Bottom: After paramedical tattoos


Top: Before paramedical tattoos (areola restoration)

Bottom: After paramedical tattoos

Beyond Body Art

The recognition of paramedical tattoo artists’ ability is particularly key for this procedure, because the skin that remains after grafting, radiation, and reconstructive surgeries is not the same as untouched skin. It is often fibrotic, thinned, and heavily scarred. Tattooing on such a canvas requires more than artistic talent—it demands clinical sensitivity, advanced knowledge of various techniques, and a deep understanding of skin trauma.

Even experienced traditional tattoo artists may feel unprepared or intimidated by the complexity of this work. And rightly so—this is not simply body art. Medical tattooing is emotional, nuanced, and often sacred work. Survivors come to the table with grief, anxiety, fear, and hope. To serve them profound, timeless results, artists must be trained in both skill and compassion.

I have spent years refining the techniques necessary to safely and effectively tattoo compromised skin. I assess not just color and symmetry, but tissue density, healing timelines, and scar behavior. Still, no 2 patients are the same. Some cry with relief when they see the finished result. Others sit in silence, taking in the sight of a body that finally feels like their own again. The effect of areola restoration tattoos extends far beyond cosmetic aesthetics. For many survivors, it is the final piece of the healing puzzle, a deeply personal symbol that says, “I am me again.”

Clients have confided in me about the discomfort they have felt when undressing in front of their loved ones. Some say they avoid mirrors. Others admit they still only see cancer when they look at their reflection, even years after their last treatment. The scars left by cancer are not just physical—they are often accompanied by immense mental strain.

Areola tattoos, when done well, can begin to rewrite that story. They transform a visible reminder of illness into a quiet return to normalcy. Normalcy in the wake of breast cancer is not a small thing. It is everything.

Providing Comprehensive, Restorative Care

As the need for areola tattoos becomes increasingly prevalent within the cancer community, it is important that the tattoos being produced are up to par. Physicians, understandably, have limited time and a long list of priorities throughout the reconstruction process. However, the post-reconstruction phase is an opportunity to provide truly comprehensive care—care that sees the patient not just as a body to be treated, but as a person to be restored. Here are 3 practical, scalable ways that health care facilities can incorporate paramedical tattooing into continuous care without increasing physicians’ workload:

  1. Onsite contracting. Partnering with a certified paramedical tattoo artist to work onsite on designated days ensures quality control, patient convenience, and continuity of care. This arrangement enhances trust and allows for seamless collaboration between surgical teams and the skilled tattoo professional.
  2. Staff training programs. For institutions that want to keep services internal, experienced artists can train interested medical staff in the proper techniques needed for successful areola tattooing over compromised skin. With proper licensing and supervision, this builds internal capacity and long-term sustainability.
  3. Trusted referrals. If space or staffing limitations prevent in-house services, a curated referral network is the next best option. Referring patients to vetted, trauma-informed tattoo artists as part of their post-surgical discharge plan ensures they have access to safe, high-quality results.

Each of these approaches creates a more intentional, patient-centered pathway—one that does not treat tattooing as an afterthought, but as a respected and essential part of the healing continuum.

Financial Barriers to Paramedical Tattooing

Another barrier patients face is cost. While financial access should not be the obstacle that keeps a survivor from feeling whole, unfortunately, it often is.

At this time, many insurance providers do not fully cover the upfront costs of areola tattooing. In many cases, areola restoration is the final step of reconstruction, so patients have exhausted their financial resources over the last year or 2 years of treatment. Consequently, many women must forego this crucial service, despite its benefits for their self-image, self-acceptance, and mental health. Facilities incorporating paramedical tattoos can ease this financial burden by:

  • Including tattooing services in the upfront surgical billing, when medically appropriate
  • Providing code-specific invoices that make patient reimbursement more feasible
  • Educating billing teams and patients on how to advocate for coverage under existing policies.

An Opportunity to Restore Dignity and Confidence

One of the most profound parts of my work is being present at the very end of someone’s breast cancer journey. I meet patients when the surgeries are over, the chemotherapy is complete, and the radiation is behind them—and still, something is missing. We can give it back to them. The gratitude I receive at the end of each session is overwhelming: tears, hugs, quiet disbelief. One woman confided the previous shame she had felt when her younger daughter first saw her reconstructed breasts. Another told me, “This is the first time I’ve recognized myself in years.”

These moments remind me that breast cancer care should not end at the removal of disease. It should continue until the person feels fully seen, fully whole, and fully themselves again. If we are to truly support survivors—not just as patients, but as human beings—we must expand the definition of care. Continuous cancer care does not mean never-ending medical appointments and therapy sessions. It means acknowledging that healing is a journey with many layers, some of which extend far beyond the hospital walls.

Paramedical tattooing is one of the most human, impactful, and underutilized tools we have in this space. It is time we give it the recognition, respect, and integration it deserves. Cancer steals so much—health, time, peace, identity. But through thoughtful, continuous care, we have the power to give something back. We have the chance to restore dignity, confidence, and even joy.

Areola restoration tattoos are not simply cosmetic procedures. They are acts of closure, healing, and reclamation. They help survivors feel like themselves again—not just survivors, but women, partners, mothers, professionals, and individuals who have endured the unimaginable and emerged with strength, grace, and resilience.

Breast cancer survivors deserve nothing less than care that honors their entire journey, from diagnosis to full restoration. As phenomenal as it is to ring the bell that screams you are cancer-free, for some, it is even more remarkable to finally embody again what many of us take for granted: normalcy.

Taylor Keeney is an areola restoration tattoo artist, a licensed esthetician, and the owner of TayK Cosmetics.

References

1. Assembly Bill A5729A. The New York State Senate. Accessed November 13, 2025. https://www.nysenate.gov/legislation/bills/2023/A5729/amendment/A

2. Women’s health and cancer rights act (WHCRA). CMS.gov. Updated September 10, 2024. Accessed November 13, 2025. https://www.cms.gov/cciio/ programs-and-initiatives/other-insurance-protections/whcra_factsheet

Articles in this issue

Honoring Progress, Inspiring What Comes Next in Oncology
Honoring Progress, Inspiring What Comes Next in Oncology
Designing the Future of Oncology Care—Together
Designing the Future of Oncology Care—Together
Primary Care Meets Cancer Prevention: Insights From Sanford World Clinic – Ghana
Primary Care Meets Cancer Prevention: Insights From Sanford World Clinic – Ghana
On Target: A Data-Driven Approach to Upgrading Radiotherapy Equipment
On Target: A Data-Driven Approach to Upgrading Radiotherapy Equipment
Demystifying Decentralization in Therapeutic Clinical Trials
Demystifying Decentralization in Therapeutic Clinical Trials
Language as Care: Transforming Patient Experience Through Better Communication
Language as Care: Transforming Patient Experience Through Better Communication
Impact of RDN-Led Nutrition Education: A Multiyear Study
Impact of RDN-Led Nutrition Education: A Multiyear Study
Patient-Derived Organoids Streamline Development and Testing of Drugs for Individualized Cancer Care
Patient-Derived Organoids Streamline Development and Testing of Drugs for Individualized Cancer Care
Artistic Interventions in Cancer Care: Orlando Health Cancer Institute's Evidence-Based Arts in Medicine Program
Artistic Interventions in Cancer Care: Orlando Health Cancer Institute's Evidence-Based Arts in Medicine Program
Fast Facts Vol. 41, No. 2
Fast Facts Vol. 41, No. 2
Legislative and Regulatory Updates
Legislative and Regulatory Updates
Due Diligence in Limiting Payer Denials
Due Diligence in Limiting Payer Denials
Restoring Wholeness: The Role of Paramedical Tattooing in Continuous Cancer Care
Restoring Wholeness: The Role of Paramedical Tattooing in Continuous Cancer Care
St. Luke’s Hospital,  Chesterfield, Missouri
St. Luke’s Hospital, Chesterfield, Missouri
Action: Vol. 41, No. 2
Action: Vol. 41, No. 2

Upcoming Events

ACCC 43rd National Oncology Conference

ACCC 43rd National Oncology Conference

In Person October 21, 2026 at 8:00 AM EDT450 Summer St, Boston, MA 02210, USAOmni Boston Hotel at the Seaport, Boston
Register Now!
ACCC Oncology Reimbursement Meeting | Reno

ACCC Oncology Reimbursement Meeting | Reno

In Person November 4, 2026 at 8:00 AM EST255 North Virginia Street, Reno, NV, USAWhitney Peak Hotel Reno, Tapestry Collection by Hilton,
Register Now!
ACCC Oncology Reimbursement Meeting | Providence

ACCC Oncology Reimbursement Meeting | Providence

In Person November 10, 2026 at 8:00 AM EST5 Avenue of the Arts, Providence, RI, USARenaissance Providence Downtown Hotel,
Register Now!
IOS Evansville Meeting
Oncology

IOS Evansville Meeting

In Person Conference & ConventionAugust 18, 2026 at 5:30 PM CDT4011 Gateway Blvd, Newburgh, IN 47630, USADeaconess Gateway Hospital , Newburgh
Register Now!
2026 Carolinas Cancer Conference
Oncology

2026 Carolinas Cancer Conference

In Person Conference & ConventionAugust 22, 2026 at 7:00 AM EDT5757 Palm Blvd, Isle of Palms, SC, USAWild Dunes, Isle of Palms
Register Now!
IOS 2026 Best of ASCO
Oncology

IOS 2026 Best of ASCO

In Person Conference & ConventionAugust 22, 2026 at 6:30 AM CDT300 East 9th Street, Coralville, IA, USAHyatt Regency Coralville Hotel & Conference Center, Coralville
Register Now!
NMSCO 2026 Fall Conference
Oncology

NMSCO 2026 Fall Conference

In Person Conference & ConventionSeptember 12, 2026 at 7:30 AM MDT2101 Louisiana Boulevard NE Albuquerque, NM, 87110Marriott Albuquerque, Albuquerque
Register Now!
TxSCO 2026 Annual Conference
Oncology

TxSCO 2026 Annual Conference

In Person Conference & ConventionSeptember 18, 2026 at 6:00 PM CDT501 Gaylord Trail, Grapevine, TX, USAGaylord Texan Resort & Convention Center, Grapevine
Register Now!
KYSCO 2026 Fall Oncology Review
Oncology

KYSCO 2026 Fall Oncology Review

In Person Conference & ConventionSeptember 19, 2026 at 7:00 AM EDT500 S 4th St, Louisville, KY, USAThe Seelbach Hilton Louisville, Louisville
Register Now!
ESHOS Horizons 2026
Oncology

ESHOS Horizons 2026

In Person Conference & ConventionSeptember 19, 2026 at 7:30 AM EDT1 Liberty Street, New York, NY, USAConvene at One Liberty Plaza, New York
Register Now!
Advertisement
Advertisement

Trending Now on
ACCCBuzz Blog

Transforming Access to Care Through Pre-Intake Navigation

Transforming Access to Care Through Pre-Intake Navigation

The University of Texas MD Anderson Cancer Center in Houston, Texas, developed a novel Pre-Intake Navigation (PIN) program, which identifies and resolves early financial and insurance barriers, enabling patients to access timely, high-quality cancer care with less anxiety and fewer delays. PIN shifts financial navigation from a late-stage, reactive task to an early, standardized, patient‑centered process embedded in the call center workflow.

An APP-Led Outpatient Bispecific Antibody Clinic

An APP-Led Outpatient Bispecific Antibody Clinic

Understanding both the benefits to be had from offering BsAb therapy to its community and the scope of this undertaking, Vanderbilt-Ingram Cancer Center took a novel approach with its APP-led BsAb step-up dosing clinic, which won the program a 2026 ACCC Innovator Award.

Advancing Critical Priorities at the State Level: Louisiana, Iowa, and Washington Awarded for Their Efforts at 2026 ASCO Annual Meeting

Advancing Critical Priorities at the State Level: Louisiana, Iowa, and Washington Awarded for Their Efforts at 2026 ASCO Annual Meeting

At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.

Designing a Safe, Fully Outpatient CAR T-Cell Program in the Community

Designing a Safe, Fully Outpatient CAR T-Cell Program in the Community

Nationally, approximately 1 in 5 patients who qualify for CAR T-cell therapy never receive it due to geographic distance, travel burden, or limited availability at specialized inpatient centers. Recognizing a critical need in its community, Mary Bird Perkins Cancer Center in Baton Rouge, Louisiana, launched the region’s first fully outpatient CAR T-cell therapy program for select blood cancers, fundamentally redefining how advanced cellular therapies can be delivered safely outside of a hospital setting and earning the program a 2026 ACCC Innovator Award.

View All ACCCBuzz Blogs

Recently Heard on
CANCER BUZZ Podcast

Utilizing APPs to Deliver Bispecific Antibodies in the Outpatient Setting - [Mini Podcast] Ep. 238

Between the Orders and the Infusion: The Patient Experience of Bispecific Antibodies - [Podcast] Ep. 237

Centering Compassion in Cancer Care – [Video Podcast] Ep. 64

A Pharmacist-Led Care Model for Oncolytic Virus Treatment Delivery - [Mini Podcast] Ep. 236

View All Podcasts

Latest from Oncology Issues

August 2026
August 2026
June 2026
April 2026
February 2026
December 2025
View All Oncology Issues

Join the Conversation

ACCC eXchange Digital Banner
Login